ArticleBMC microbiology2026
Genomic association of Campylobacter concisus for colonization advantages and virulence in children and adolescents with inflammatory bowel disease.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundInflammatory bowel disease (IBD) is characterized by a dysbiosis of the intestinal microbiota, where oral microbes may benefit from resulting niches and colonize the intestine. We investigated Campylobacter (C.) concisus, an oral commensal and suspected intestinal pathogen in IBD, for genomic features facilitating intestinal colonization. We aimed to validate suggested virulence factors in IBD and to uncover patterns of propagation within and between hosts of C. concisus.
methodsWe cultured C. concisus in a retrospective cohort of pediatric patients with IBD and with acute enteritis as diseased non-IBD controls from stool samples. In addition, in a prospective cohort of pediatric IBD patients we repeatedly collected saliva and stool samples for culturing. Whole genomes of C. concisus were compared for genomic similarity, virulence factors and antibiotic resistance genes dependent upon sample locations and disease groups. We also determined associations between genomic determinants and IBD phenotypes.
resultsThe resulting 40 C. concisus genomes (19 saliva IBD, 13 stool IBD, 8 stool non-IBD) showed a high genomic diversity within and between sample locations and disease groups. We found multiple colonization scenarios in regards to sample locations, timing and genomic diversity in the IBD cohort. C. concisus IBD genomes were evenly distributed between the two genome species GS1 and GS2 and we found no difference between disease groups with regards to the tested virulence factors. Interestingly, only C. concisus IBD genomes harbored a gyrA_T86I mutation with phenotypically confirmed ciprofloxacin resistance independent of previous ciprofloxacin exposure. We found no indication of IBD phenotypes supporting intestinal colonization besides clinical active disease. All C. concisus strains contained genes that enable nitrate utilization (napAGH), as an indicator of the ability to adapt their energy metabolism.
conclusionOur data do not support a role of previously suggested IBD associated virulence factors. Instead, they point to the possibility that C. concisus adapts to intestinal inflammation due to its genetic predisposition to alter its energy metabolism independent of IBD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.